Higher open eyed on pharma M&A, GE rating view

NEW YORK (Reuters) – Stocks were set to rise at the open on Monday as news of a multi-billion dollar takeover in the drug industry buoyed sentiment and a credit rating agency offered some reassurance about its rating view for General Electric .

Leave a Reply